This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Chubb's (CB) Q3 Earnings Coming Up: What's in the Cards?
by Zacks Equity Research
Chubb's (CB) Q3 earnings are likely to reflect higher premiums and improved net investment income, offset by higher expenses.
W.R. Berkley (WRB) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Higher premium growth, increased net investment income and an improved expense ratio are likely to have aided W.R. Berkley's (WRB) third-quarter performance. The results are likely to be partly offset by higher expenses.
Is a Beat in Store for Marsh & McLennan (MMC) in Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to reflect revenue and earnings growth owing to solid performances by its Risk and Insurance Services, and Consulting segments.
What's in the Cards for Travelers (TRV) in Q3 Earnings?
by Zacks Equity Research
Travelers' (TRV) third-quarter results are likely to reflect new business premiums, strong retention rates, better pricing, partly offset by higher expenses.
Reasons Why EverQuote (EVER) Stock is an Attractive Pick
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, solid performance of automotive insurance providers and financial flexibility.
Best Income Stocks to Buy for October 12th
by Zacks Equity Research
OUT, FISI and CNO made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 12, 2022.
New Strong Buy Stocks for October 12th
by Zacks Equity Research
COUP, AINC, CHS, CNO and AVNW have been added to the Zacks Rank #1 (Strong Buy) List on October 12, 2022.
Should Value Investors Buy CNO Financial Group (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Add Radian Group (RDN) to Your Portfolio
by Zacks Equity Research
Improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment and solid capital position poise Radian Group (RDN) well for growth.
Best Momentum Stocks to Buy for October 4th
by Zacks Equity Research
RWEOY, CNO and ENPH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 4, 2022.
Is Axa (AXAHY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Is MetLife (MET) Up 1.6% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO (CNO) Up 2.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO Financial (CNO) Up 2% on Q2 Earnings Beat on Lower Costs
by Zacks Equity Research
CNO Financial's (CNO) second-quarter results reflect a solid variable investment income, higher annuity collected premiums and a fall in benefits and expenses.
CNO Financial (CNO) Tops Q2 Earnings Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 80.85% and 4.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
PCB Bancorp (PCB) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
PCB Bancorp (PCB) delivered earnings and revenue surprises of -4.76% and 3.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Assurant (AIZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate CNO Financial (CNO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNO Financial (CNO) Unit Upgrades Medicare Supplement Plans
by Zacks Equity Research
CNO Financial's (CNO) unit Bankers Life brings a portfolio of Medicare Supplement insurance plans that are attached with alluring benefits and shield Americans from unanticipated expenses.
Why Is CNO (CNO) Down 4.2% Since Last Earnings Report?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for May 16th
by Zacks Equity Research
ATCO, CNO, and LOB have been added to the Zacks Rank #5 (Strong Sell) List on May 16, 2022.
CNO Financial (CNO) Down 15% as Q1 Earnings & Revenue Miss
by Zacks Equity Research
CNO Financial's (CNO) first-quarter results suffer from market volatility and higher non-deferrable advertising spend. Management forecasts consistent positive momentum in sales in 2022.
CNO Financial (CNO) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of -26.32% and 7.97%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
CNO Financial (CNO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CNO (CNO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why is Hold Strategy Appropriate for CNO Financial (CNO)?
by Zacks Equity Research
CNO Financial (CNO) has enough potential to reap benefits for investors owing to strong investments in technology and cost-cutting measures.